Eleonore Spitzer
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.
Journal: JHEP reports : innovation in hepatology
Published: February 16, 2026
Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French Genomic Medicine Initiative.
Journal: Journal of hepatology
Published: October 17, 2025
Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French genomic medicine initiative.
Journal: Journal of hepatology
Published: October 17, 2025
Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI.
Journal: Journal of hepatology
Published: October 10, 2025
Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and Decompensation.
Journal: Journal of hepatology
Published: October 10, 2025
Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study.
Journal: Hepatology international
Published: June 17, 2025
Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE.
Journal: Clinics and research in hepatology and gastroenterology
Published: August 26, 2024
Pembrolizumab with trastuzumab and chemotherapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS≥1
Journal: Bulletin du cancer
Published: October 27, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026